Table 7 Subpopulations discovered by the C-IBP, only considering the high exposure group and placebo group
From: Case-control Indian buffet process identifies biomarkers of response to Codrituzumab
Sub-population | Drug Identifier | F1 | F2 | F3 | Average num. of patients | Mean PFS (months) | Median PFS (months) |
|---|---|---|---|---|---|---|---|
1. | 0 | 0 | 0 | 0 | 33.16 | 3.07 | 1.65 |
2. | 0 | 0 | 1 | 0 | 4.17 | 2.30 | 2.21 |
3. | 0 | 1 | 0 | 0 | 17.96 | 2.70 | 1.81 |
4. | 0 | 1 | 1 | 0 | 4.71 | 7.02 | 7.15 |
5. | 1 | 0 | 0 | 0 | 25.67 | 4.15 | 3.93 |
6. | 1 | 0 | 0 | 1 | 6.72 | 4.64 | 4.23 |
7. | 1 | 0 | 1 | 0 | 4.23 | 2.96 | 2.29 |
8. | 1 | 0 | 1 | 1 | 1.37 | 3.69 | 3.67 |
9. | 1 | 1 | 0 | 0 | 14.63 | 3.62 | 2.66 |
10. | 1 | 1 | 0 | 1 | 1.55 | 5.94 | 5.93 |
11. | 1 | 1 | 1 | 0 | 3.86 | 6.23 | 5.37 |
12. | 1 | 1 | 1 | 1 | 1.98 | 10.63 | 10.62 |
Total | 60.00 | 44.69 | 20.31 | 11.61 | 120 | 3.78 | 2.76 |